Form D · Pharmaceuticals

Cahaba Pharmaceuticals, LLC

Princeton, NJ · CIK 0001460300

Offering snapshot reported Jan 18, 2013 · SEC filing

Reported sold
$205K
Offering amount: $1M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 9, 2013
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 18, 2013Initial$205,000No comparison0SEC filing
Mar 22, 2012Initial$250,000No comparison1SEC filing
Dec 17, 2010InitialYet to sellNo comparison0SEC filing
Oct 28, 2010Initial$500,000No comparison1SEC filing
May 29, 2009Amendment$831,959No comparisonNot reportedSEC filing
Mar 30, 2009InitialYet to sellNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$16.4K (estimated)
Finders' fees
$0
Form D file number
021-190531

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Julio A. Marquez2261430Gottbetter Capital Markets, LLC · CRD 20680
Stephen Renaud1476612Gottbetter Capital Markets, LLC · CRD 20680

Source: Form D, filed Jan 18, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

CAHABA PHARMACEUTICALS, LLC

Investment adviser: BROOKLINE INVESTMENTS, INC.

Gross asset value
$38.5K
Beneficial owners
43
ADV minimum commitment
$25K

Reported in Form ADV on Feb 22, 2024. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Auditor DIPIAZZA LAROCCA HEETER & CO., LLC MOUNTAIN BROOK, Alabama, United States
Custodian FIRST HORIZON BANK BIRMINGHAM, Alabama, United States Related to adviser: No
Custodian STIFEL, NICOLAUS & COMPANY, INCORPORATED BIRMINGHAM, Alabama, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
No
External marketing
No

DIPIAZZA LAROCCA HEETER & CO., LLC
PCAOB 5903

STIFEL, NICOLAUS & COMPANY, INCORPORATED
SEC 8-1447

Filing source

Form ADV 1831354 · Feb 22, 2024 · Schedule D 7.B.(1), fund 805-5749531683

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew P. Aromando Executive
James E. Cantrell, Jr. Director
Jimmie Huling Harvey, Jr. Director
Madding King, Iii Director, Executive
William M Testa Executive
J. Rainer Twiford Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
103 Carnegie Center Suite 300
Princeton, NJ, 08540